nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—CES2—Irinotecan—colon cancer	0.168	0.279	CbGbCtD
Mycophenolate mofetil—ABCB1—colon cancer	0.166	1	CbGaD
Mycophenolate mofetil—CES1—Capecitabine—colon cancer	0.0943	0.157	CbGbCtD
Mycophenolate mofetil—CES1—Irinotecan—colon cancer	0.0583	0.0969	CbGbCtD
Mycophenolate mofetil—UGT1A9—Irinotecan—colon cancer	0.0354	0.0588	CbGbCtD
Mycophenolate mofetil—UGT1A1—Irinotecan—colon cancer	0.0289	0.0481	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Irinotecan—colon cancer	0.02	0.0333	CbGbCtD
Mycophenolate mofetil—SLCO1B3—Methotrexate—colon cancer	0.0182	0.0303	CbGbCtD
Mycophenolate mofetil—ABCC2—Irinotecan—colon cancer	0.0176	0.0293	CbGbCtD
Mycophenolate mofetil—ABCG2—Irinotecan—colon cancer	0.0159	0.0265	CbGbCtD
Mycophenolate mofetil—ABCC2—Vincristine—colon cancer	0.0154	0.0256	CbGbCtD
Mycophenolate mofetil—ABCG2—Fluorouracil—colon cancer	0.0153	0.0254	CbGbCtD
Mycophenolate mofetil—ABCG2—Vincristine—colon cancer	0.0139	0.0231	CbGbCtD
Mycophenolate mofetil—ALB—Irinotecan—colon cancer	0.011	0.0182	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Methotrexate—colon cancer	0.0106	0.0176	CbGbCtD
Mycophenolate mofetil—ALB—Fluorouracil—colon cancer	0.0105	0.0175	CbGbCtD
Mycophenolate mofetil—ABCC2—Methotrexate—colon cancer	0.00931	0.0155	CbGbCtD
Mycophenolate mofetil—CYP3A5—Irinotecan—colon cancer	0.00881	0.0147	CbGbCtD
Mycophenolate mofetil—ABCG2—Methotrexate—colon cancer	0.00842	0.014	CbGbCtD
Mycophenolate mofetil—CYP2C8—Fluorouracil—colon cancer	0.00813	0.0135	CbGbCtD
Mycophenolate mofetil—CYP3A5—Vincristine—colon cancer	0.0077	0.0128	CbGbCtD
Mycophenolate mofetil—ALB—Methotrexate—colon cancer	0.0058	0.00965	CbGbCtD
Mycophenolate mofetil—ABCB1—Irinotecan—colon cancer	0.00574	0.00954	CbGbCtD
Mycophenolate mofetil—ABCB1—Vincristine—colon cancer	0.00501	0.00834	CbGbCtD
Mycophenolate mofetil—ABCC2—bile—colon cancer	0.00351	0.0598	CbGeAlD
Mycophenolate mofetil—CYP3A4—Irinotecan—colon cancer	0.00344	0.00571	CbGbCtD
Mycophenolate mofetil—ABCB1—Methotrexate—colon cancer	0.00304	0.00505	CbGbCtD
Mycophenolate mofetil—CYP3A4—Vincristine—colon cancer	0.003	0.00499	CbGbCtD
Mycophenolate mofetil—UGT1A7—renal system—colon cancer	0.00257	0.0439	CbGeAlD
Mycophenolate mofetil—UGT1A10—renal system—colon cancer	0.00215	0.0367	CbGeAlD
Mycophenolate mofetil—UGT1A7—digestive system—colon cancer	0.00211	0.036	CbGeAlD
Mycophenolate mofetil—UGT1A10—digestive system—colon cancer	0.00176	0.0301	CbGeAlD
Mycophenolate mofetil—UGT1A8—renal system—colon cancer	0.0017	0.029	CbGeAlD
Mycophenolate mofetil—UGT1A6—digestive system—colon cancer	0.00164	0.028	CbGeAlD
Mycophenolate mofetil—UGT1A7—liver—colon cancer	0.00157	0.0268	CbGeAlD
Mycophenolate mofetil—CES1—gall bladder—colon cancer	0.00149	0.0255	CbGeAlD
Mycophenolate mofetil—UGT1A8—digestive system—colon cancer	0.00139	0.0238	CbGeAlD
Mycophenolate mofetil—UGT1A10—liver—colon cancer	0.00131	0.0224	CbGeAlD
Mycophenolate mofetil—UGT1A6—liver—colon cancer	0.00122	0.0209	CbGeAlD
Mycophenolate mofetil—UGT1A9—renal system—colon cancer	0.00108	0.0184	CbGeAlD
Mycophenolate mofetil—UGT1A8—liver—colon cancer	0.00104	0.0177	CbGeAlD
Mycophenolate mofetil—ALB—gall bladder—colon cancer	0.00104	0.0177	CbGeAlD
Mycophenolate mofetil—IMPDH2—smooth muscle tissue—colon cancer	0.000995	0.017	CbGeAlD
Mycophenolate mofetil—IMPDH1—smooth muscle tissue—colon cancer	0.000989	0.0169	CbGeAlD
Mycophenolate mofetil—IMPDH2—renal system—colon cancer	0.000958	0.0163	CbGeAlD
Mycophenolate mofetil—IMPDH1—renal system—colon cancer	0.000952	0.0162	CbGeAlD
Mycophenolate mofetil—CES2—smooth muscle tissue—colon cancer	0.000904	0.0154	CbGeAlD
Mycophenolate mofetil—UGT1A9—digestive system—colon cancer	0.000886	0.0151	CbGeAlD
Mycophenolate mofetil—CES2—renal system—colon cancer	0.000871	0.0149	CbGeAlD
Mycophenolate mofetil—UGT2B7—renal system—colon cancer	0.000871	0.0149	CbGeAlD
Mycophenolate mofetil—IMPDH2—lymphoid tissue—colon cancer	0.000795	0.0136	CbGeAlD
Mycophenolate mofetil—IMPDH1—lymphoid tissue—colon cancer	0.00079	0.0135	CbGeAlD
Mycophenolate mofetil—IMPDH2—digestive system—colon cancer	0.000786	0.0134	CbGeAlD
Mycophenolate mofetil—SLCO1B3—vagina—colon cancer	0.000771	0.0132	CbGeAlD
Mycophenolate mofetil—UGT1A1—renal system—colon cancer	0.00074	0.0126	CbGeAlD
Mycophenolate mofetil—IMPDH2—bone marrow—colon cancer	0.000724	0.0124	CbGeAlD
Mycophenolate mofetil—IMPDH1—bone marrow—colon cancer	0.00072	0.0123	CbGeAlD
Mycophenolate mofetil—CES2—digestive system—colon cancer	0.000714	0.0122	CbGeAlD
Mycophenolate mofetil—UGT2B7—digestive system—colon cancer	0.000714	0.0122	CbGeAlD
Mycophenolate mofetil—IMPDH2—vagina—colon cancer	0.000694	0.0118	CbGeAlD
Mycophenolate mofetil—IMPDH1—vagina—colon cancer	0.000689	0.0118	CbGeAlD
Mycophenolate mofetil—UGT1A9—liver—colon cancer	0.00066	0.0113	CbGeAlD
Mycophenolate mofetil—CES2—bone marrow—colon cancer	0.000658	0.0112	CbGeAlD
Mycophenolate mofetil—SLCO1B3—liver—colon cancer	0.000651	0.0111	CbGeAlD
Mycophenolate mofetil—CES2—vagina—colon cancer	0.000631	0.0108	CbGeAlD
Mycophenolate mofetil—SLCO1B1—renal system—colon cancer	0.000616	0.0105	CbGeAlD
Mycophenolate mofetil—UGT1A1—digestive system—colon cancer	0.000607	0.0104	CbGeAlD
Mycophenolate mofetil—CES1—lymphoid tissue—colon cancer	0.000595	0.0102	CbGeAlD
Mycophenolate mofetil—CES1—digestive system—colon cancer	0.000588	0.01	CbGeAlD
Mycophenolate mofetil—IMPDH2—liver—colon cancer	0.000585	0.00999	CbGeAlD
Mycophenolate mofetil—IMPDH1—liver—colon cancer	0.000582	0.00992	CbGeAlD
Mycophenolate mofetil—CES2—liver—colon cancer	0.000532	0.00908	CbGeAlD
Mycophenolate mofetil—UGT2B7—liver—colon cancer	0.000532	0.00908	CbGeAlD
Mycophenolate mofetil—SLCO1B1—digestive system—colon cancer	0.000505	0.00862	CbGeAlD
Mycophenolate mofetil—ABCC2—renal system—colon cancer	0.000467	0.00797	CbGeAlD
Mycophenolate mofetil—UGT1A1—liver—colon cancer	0.000452	0.00772	CbGeAlD
Mycophenolate mofetil—IMPDH2—lymph node—colon cancer	0.000449	0.00766	CbGeAlD
Mycophenolate mofetil—IMPDH1—lymph node—colon cancer	0.000446	0.00761	CbGeAlD
Mycophenolate mofetil—CES1—liver—colon cancer	0.000438	0.00747	CbGeAlD
Mycophenolate mofetil—CES2—lymph node—colon cancer	0.000408	0.00696	CbGeAlD
Mycophenolate mofetil—ABCC2—digestive system—colon cancer	0.000383	0.00653	CbGeAlD
Mycophenolate mofetil—SLCO1B1—liver—colon cancer	0.000376	0.00642	CbGeAlD
Mycophenolate mofetil—ABCB1—blood vessel—colon cancer	0.000372	0.00635	CbGeAlD
Mycophenolate mofetil—CYP2C8—renal system—colon cancer	0.00035	0.00598	CbGeAlD
Mycophenolate mofetil—CES1—lymph node—colon cancer	0.000336	0.00573	CbGeAlD
Mycophenolate mofetil—CYP3A5—renal system—colon cancer	0.000316	0.00539	CbGeAlD
Mycophenolate mofetil—ALB—liver—colon cancer	0.000304	0.0052	CbGeAlD
Mycophenolate mofetil—ABCC2—liver—colon cancer	0.000285	0.00487	CbGeAlD
Mycophenolate mofetil—CYP3A5—digestive system—colon cancer	0.000259	0.00442	CbGeAlD
Mycophenolate mofetil—ABCG2—bone marrow—colon cancer	0.000257	0.00439	CbGeAlD
Mycophenolate mofetil—CYP2C8—vagina—colon cancer	0.000254	0.00433	CbGeAlD
Mycophenolate mofetil—ABCG2—vagina—colon cancer	0.000247	0.00421	CbGeAlD
Mycophenolate mofetil—CYP3A4—renal system—colon cancer	0.000237	0.00405	CbGeAlD
Mycophenolate mofetil—ALB—lymph node—colon cancer	0.000233	0.00398	CbGeAlD
Mycophenolate mofetil—CYP3A5—vagina—colon cancer	0.000229	0.00391	CbGeAlD
Mycophenolate mofetil—ABCB1—embryo—colon cancer	0.000222	0.00378	CbGeAlD
Mycophenolate mofetil—ABCC2—lymph node—colon cancer	0.000219	0.00373	CbGeAlD
Mycophenolate mofetil—CYP2C8—liver—colon cancer	0.000214	0.00365	CbGeAlD
Mycophenolate mofetil—ABCG2—liver—colon cancer	0.000208	0.00355	CbGeAlD
Mycophenolate mofetil—CYP3A4—digestive system—colon cancer	0.000195	0.00332	CbGeAlD
Mycophenolate mofetil—CYP3A5—liver—colon cancer	0.000193	0.0033	CbGeAlD
Mycophenolate mofetil—ABCB1—epithelium—colon cancer	0.000181	0.00309	CbGeAlD
Mycophenolate mofetil—ABCB1—renal system—colon cancer	0.000168	0.00286	CbGeAlD
Mycophenolate mofetil—ABCG2—lymph node—colon cancer	0.00016	0.00272	CbGeAlD
Mycophenolate mofetil—CYP3A4—liver—colon cancer	0.000145	0.00247	CbGeAlD
Mycophenolate mofetil—ABCB1—lymphoid tissue—colon cancer	0.000139	0.00238	CbGeAlD
Mycophenolate mofetil—ABCB1—digestive system—colon cancer	0.000138	0.00235	CbGeAlD
Mycophenolate mofetil—ABCB1—bone marrow—colon cancer	0.000127	0.00217	CbGeAlD
Mycophenolate mofetil—ABCB1—vagina—colon cancer	0.000122	0.00208	CbGeAlD
Mycophenolate mofetil—Oedema—Irinotecan—colon cancer	0.000103	0.000796	CcSEcCtD
Mycophenolate mofetil—ABCB1—liver—colon cancer	0.000103	0.00175	CbGeAlD
Mycophenolate mofetil—Chest pain—Fluorouracil—colon cancer	0.000103	0.000796	CcSEcCtD
Mycophenolate mofetil—Myalgia—Fluorouracil—colon cancer	0.000103	0.000796	CcSEcCtD
Mycophenolate mofetil—Infection—Irinotecan—colon cancer	0.000102	0.000791	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Vincristine—colon cancer	0.000102	0.000791	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Capecitabine—colon cancer	0.000102	0.00079	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Capecitabine—colon cancer	0.000102	0.000788	CcSEcCtD
Mycophenolate mofetil—Discomfort—Fluorouracil—colon cancer	0.000101	0.000786	CcSEcCtD
Mycophenolate mofetil—Shock—Irinotecan—colon cancer	0.000101	0.000783	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Irinotecan—colon cancer	0.000101	0.000781	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Capecitabine—colon cancer	0.000101	0.00078	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Irinotecan—colon cancer	0.000101	0.00078	CcSEcCtD
Mycophenolate mofetil—Anorexia—Vincristine—colon cancer	0.0001	0.000779	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Irinotecan—colon cancer	9.93e-05	0.00077	CcSEcCtD
Mycophenolate mofetil—Confusional state—Fluorouracil—colon cancer	9.91e-05	0.000769	CcSEcCtD
Mycophenolate mofetil—Mood swings—Methotrexate—colon cancer	9.86e-05	0.000765	CcSEcCtD
Mycophenolate mofetil—Hypotension—Vincristine—colon cancer	9.85e-05	0.000764	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Capecitabine—colon cancer	9.85e-05	0.000764	CcSEcCtD
Mycophenolate mofetil—Oedema—Fluorouracil—colon cancer	9.83e-05	0.000763	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Fluorouracil—colon cancer	9.83e-05	0.000763	CcSEcCtD
Mycophenolate mofetil—Anorexia—Irinotecan—colon cancer	9.79e-05	0.000759	CcSEcCtD
Mycophenolate mofetil—Infection—Fluorouracil—colon cancer	9.77e-05	0.000758	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Capecitabine—colon cancer	9.72e-05	0.000754	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Capecitabine—colon cancer	9.7e-05	0.000752	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Capecitabine—colon cancer	9.67e-05	0.00075	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Capecitabine—colon cancer	9.67e-05	0.00075	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Fluorouracil—colon cancer	9.64e-05	0.000748	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Fluorouracil—colon cancer	9.63e-05	0.000747	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Capecitabine—colon cancer	9.62e-05	0.000746	CcSEcCtD
Mycophenolate mofetil—Liver function test abnormal—Methotrexate—colon cancer	9.61e-05	0.000745	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Vincristine—colon cancer	9.6e-05	0.000745	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Capecitabine—colon cancer	9.6e-05	0.000745	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Fluorouracil—colon cancer	9.6e-05	0.000744	CcSEcCtD
Mycophenolate mofetil—Hypotension—Irinotecan—colon cancer	9.59e-05	0.000744	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Capecitabine—colon cancer	9.55e-05	0.000741	CcSEcCtD
Mycophenolate mofetil—Insomnia—Vincristine—colon cancer	9.53e-05	0.00074	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Capecitabine—colon cancer	9.53e-05	0.000739	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Capecitabine—colon cancer	9.5e-05	0.000737	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Capecitabine—colon cancer	9.48e-05	0.000735	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Vincristine—colon cancer	9.47e-05	0.000734	CcSEcCtD
Mycophenolate mofetil—Anorexia—Fluorouracil—colon cancer	9.37e-05	0.000727	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Capecitabine—colon cancer	9.32e-05	0.000723	CcSEcCtD
Mycophenolate mofetil—Insomnia—Irinotecan—colon cancer	9.29e-05	0.00072	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—CA7—colon cancer	9.24e-05	0.00203	CbGpPWpGaD
Mycophenolate mofetil—Paraesthesia—Irinotecan—colon cancer	9.22e-05	0.000715	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	9.19e-05	0.00202	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	9.19e-05	0.00202	CbGpPWpGaD
Mycophenolate mofetil—Hypotension—Fluorouracil—colon cancer	9.19e-05	0.000713	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Vincristine—colon cancer	9.16e-05	0.000711	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Irinotecan—colon cancer	9.15e-05	0.00071	CcSEcCtD
Mycophenolate mofetil—Somnolence—Irinotecan—colon cancer	9.13e-05	0.000708	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Vincristine—colon cancer	9.1e-05	0.000706	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Capecitabine—colon cancer	9.04e-05	0.000701	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Irinotecan—colon cancer	9.04e-05	0.000701	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Capecitabine—colon cancer	9.02e-05	0.000699	CcSEcCtD
Mycophenolate mofetil—Pain—Vincristine—colon cancer	9.02e-05	0.000699	CcSEcCtD
Mycophenolate mofetil—Constipation—Vincristine—colon cancer	9.02e-05	0.000699	CcSEcCtD
Mycophenolate mofetil—Asthma—Methotrexate—colon cancer	9e-05	0.000698	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Capecitabine—colon cancer	8.98e-05	0.000696	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Fluorouracil—colon cancer	8.96e-05	0.000695	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	8.94e-05	0.00197	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	8.94e-05	0.00197	CbGpPWpGaD
Mycophenolate mofetil—Decreased appetite—Irinotecan—colon cancer	8.92e-05	0.000692	CcSEcCtD
Mycophenolate mofetil—Insomnia—Fluorouracil—colon cancer	8.89e-05	0.00069	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Irinotecan—colon cancer	8.86e-05	0.000688	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Fluorouracil—colon cancer	8.83e-05	0.000685	CcSEcCtD
Mycophenolate mofetil—Pancreatitis—Methotrexate—colon cancer	8.82e-05	0.000684	CcSEcCtD
Mycophenolate mofetil—Constipation—Irinotecan—colon cancer	8.78e-05	0.000681	CcSEcCtD
Mycophenolate mofetil—Pain—Irinotecan—colon cancer	8.78e-05	0.000681	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Capecitabine—colon cancer	8.77e-05	0.000681	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Fluorouracil—colon cancer	8.77e-05	0.00068	CcSEcCtD
Mycophenolate mofetil—Somnolence—Fluorouracil—colon cancer	8.74e-05	0.000678	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Capecitabine—colon cancer	8.72e-05	0.000676	CcSEcCtD
Mycophenolate mofetil—Chills—Capecitabine—colon cancer	8.68e-05	0.000673	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Fluorouracil—colon cancer	8.66e-05	0.000671	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Capecitabine—colon cancer	8.64e-05	0.00067	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Vincristine—colon cancer	8.62e-05	0.000669	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Fluorouracil—colon cancer	8.55e-05	0.000663	CcSEcCtD
Mycophenolate mofetil—Alopecia—Capecitabine—colon cancer	8.55e-05	0.000663	CcSEcCtD
Mycophenolate mofetil—Pancytopenia—Methotrexate—colon cancer	8.54e-05	0.000663	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Fluorouracil—colon cancer	8.49e-05	0.000658	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Capecitabine—colon cancer	8.47e-05	0.000657	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Irinotecan—colon cancer	8.46e-05	0.000656	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Capecitabine—colon cancer	8.42e-05	0.000653	CcSEcCtD
Mycophenolate mofetil—Dysuria—Methotrexate—colon cancer	8.41e-05	0.000652	CcSEcCtD
Mycophenolate mofetil—Neutropenia—Methotrexate—colon cancer	8.41e-05	0.000652	CcSEcCtD
Mycophenolate mofetil—Pain—Fluorouracil—colon cancer	8.41e-05	0.000652	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Irinotecan—colon cancer	8.4e-05	0.000651	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Vincristine—colon cancer	8.33e-05	0.000646	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Vincristine—colon cancer	8.33e-05	0.000646	CcSEcCtD
Mycophenolate mofetil—Flatulence—Capecitabine—colon cancer	8.3e-05	0.000644	CcSEcCtD
Mycophenolate mofetil—Erectile dysfunction—Methotrexate—colon cancer	8.28e-05	0.000643	CcSEcCtD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	8.28e-05	0.00182	CbGpPWpGaD
Mycophenolate mofetil—Dysgeusia—Capecitabine—colon cancer	8.24e-05	0.00064	CcSEcCtD
Mycophenolate mofetil—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	8.21e-05	0.00181	CbGpPWpGaD
Mycophenolate mofetil—Back pain—Capecitabine—colon cancer	8.14e-05	0.000632	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Irinotecan—colon cancer	8.12e-05	0.00063	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Irinotecan—colon cancer	8.12e-05	0.00063	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Fluorouracil—colon cancer	8.1e-05	0.000629	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Capecitabine—colon cancer	8.09e-05	0.000628	CcSEcCtD
Mycophenolate mofetil—Pneumonia—Methotrexate—colon cancer	8.07e-05	0.000626	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Methotrexate—colon cancer	8.02e-05	0.000622	CcSEcCtD
Mycophenolate mofetil—Infestation—Methotrexate—colon cancer	8.02e-05	0.000622	CcSEcCtD
Mycophenolate mofetil—Depression—Methotrexate—colon cancer	8e-05	0.00062	CcSEcCtD
Mycophenolate mofetil—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	7.99e-05	0.00176	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	7.99e-05	0.00176	CbGpPWpGaD
Mycophenolate mofetil—Tremor—Capecitabine—colon cancer	7.89e-05	0.000612	CcSEcCtD
Mycophenolate mofetil—Renal failure—Methotrexate—colon cancer	7.88e-05	0.000612	CcSEcCtD
Mycophenolate mofetil—ABCB1—lymph node—colon cancer	7.87e-05	0.00134	CbGeAlD
Mycophenolate mofetil—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	7.84e-05	0.00172	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	7.84e-05	0.00172	CbGpPWpGaD
Mycophenolate mofetil—Stomatitis—Methotrexate—colon cancer	7.82e-05	0.000606	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Capecitabine—colon cancer	7.81e-05	0.000606	CcSEcCtD
Mycophenolate mofetil—Urticaria—Fluorouracil—colon cancer	7.81e-05	0.000606	CcSEcCtD
Mycophenolate mofetil—Conjunctivitis—Methotrexate—colon cancer	7.8e-05	0.000605	CcSEcCtD
Mycophenolate mofetil—Anaemia—Capecitabine—colon cancer	7.78e-05	0.000604	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Fluorouracil—colon cancer	7.77e-05	0.000603	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Vincristine—colon cancer	7.77e-05	0.000602	CcSEcCtD
Mycophenolate mofetil—Sweating—Methotrexate—colon cancer	7.69e-05	0.000596	CcSEcCtD
Mycophenolate mofetil—Haematuria—Methotrexate—colon cancer	7.65e-05	0.000593	CcSEcCtD
Mycophenolate mofetil—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	7.63e-05	0.00168	CbGpPWpGaD
Mycophenolate mofetil—Malaise—Capecitabine—colon cancer	7.59e-05	0.000589	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Methotrexate—colon cancer	7.59e-05	0.000588	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Methotrexate—colon cancer	7.56e-05	0.000587	CcSEcCtD
Mycophenolate mofetil—Vertigo—Capecitabine—colon cancer	7.56e-05	0.000587	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Irinotecan—colon cancer	7.56e-05	0.000587	CcSEcCtD
Mycophenolate mofetil—Asthenia—Vincristine—colon cancer	7.56e-05	0.000587	CcSEcCtD
Mycophenolate mofetil—Syncope—Capecitabine—colon cancer	7.55e-05	0.000586	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Capecitabine—colon cancer	7.54e-05	0.000585	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Metabolism—CA7—colon cancer	7.51e-05	0.00165	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CA7—colon cancer	7.51e-05	0.00165	CbGpPWpGaD
Mycophenolate mofetil—Agranulocytosis—Methotrexate—colon cancer	7.48e-05	0.000581	CcSEcCtD
Mycophenolate mofetil—Palpitations—Capecitabine—colon cancer	7.44e-05	0.000577	CcSEcCtD
Mycophenolate mofetil—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	7.42e-05	0.00163	CbGpPWpGaD
Mycophenolate mofetil—Loss of consciousness—Capecitabine—colon cancer	7.4e-05	0.000574	CcSEcCtD
Mycophenolate mofetil—Asthenia—Irinotecan—colon cancer	7.37e-05	0.000571	CcSEcCtD
Mycophenolate mofetil—Cough—Capecitabine—colon cancer	7.35e-05	0.00057	CcSEcCtD
Mycophenolate mofetil—ABCG2—Fluoropyrimidine Activity—TP53—colon cancer	7.28e-05	0.0016	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	7.27e-05	0.0016	CbGpPWpGaD
Mycophenolate mofetil—Hypertension—Capecitabine—colon cancer	7.27e-05	0.000564	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Fluorouracil—colon cancer	7.24e-05	0.000562	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Methotrexate—colon cancer	7.24e-05	0.000561	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Vincristine—colon cancer	7.21e-05	0.000559	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Methotrexate—colon cancer	7.2e-05	0.000558	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Methotrexate—colon cancer	7.2e-05	0.000558	CcSEcCtD
Mycophenolate mofetil—Chest pain—Capecitabine—colon cancer	7.17e-05	0.000556	CcSEcCtD
Mycophenolate mofetil—Myalgia—Capecitabine—colon cancer	7.17e-05	0.000556	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Capecitabine—colon cancer	7.17e-05	0.000556	CcSEcCtD
Mycophenolate mofetil—UGT1A6—NRF2 pathway—TGFB1—colon cancer	7.15e-05	0.00157	CbGpPWpGaD
Mycophenolate mofetil—Pharyngitis—Methotrexate—colon cancer	7.15e-05	0.000554	CcSEcCtD
Mycophenolate mofetil—Anxiety—Capecitabine—colon cancer	7.14e-05	0.000554	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	7.12e-05	0.000552	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Methotrexate—colon cancer	7.11e-05	0.000552	CcSEcCtD
Mycophenolate mofetil—Discomfort—Capecitabine—colon cancer	7.08e-05	0.000549	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Methotrexate—colon cancer	7.06e-05	0.000547	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Irinotecan—colon cancer	7.02e-05	0.000545	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Capecitabine—colon cancer	7.01e-05	0.000544	CcSEcCtD
Mycophenolate mofetil—UGT1A9—PPARA activates gene expression—PPARG—colon cancer	7e-05	0.00154	CbGpPWpGaD
Mycophenolate mofetil—Dizziness—Vincristine—colon cancer	6.97e-05	0.000541	CcSEcCtD
Mycophenolate mofetil—Pruritus—Fluorouracil—colon cancer	6.96e-05	0.00054	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Methotrexate—colon cancer	6.94e-05	0.000538	CcSEcCtD
Mycophenolate mofetil—Confusional state—Capecitabine—colon cancer	6.93e-05	0.000537	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Metabolism—CA7—colon cancer	6.88e-05	0.00151	CbGpPWpGaD
Mycophenolate mofetil—Oedema—Capecitabine—colon cancer	6.87e-05	0.000533	CcSEcCtD
Mycophenolate mofetil—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	6.85e-05	0.00151	CbGpPWpGaD
Mycophenolate mofetil—Infection—Capecitabine—colon cancer	6.83e-05	0.00053	CcSEcCtD
Mycophenolate mofetil—CES1—NRF2 pathway—TGFB1—colon cancer	6.8e-05	0.0015	CbGpPWpGaD
Mycophenolate mofetil—Dizziness—Irinotecan—colon cancer	6.79e-05	0.000527	CcSEcCtD
Mycophenolate mofetil—Shock—Capecitabine—colon cancer	6.76e-05	0.000524	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Capecitabine—colon cancer	6.74e-05	0.000523	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Methotrexate—colon cancer	6.73e-05	0.000522	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Fluorouracil—colon cancer	6.73e-05	0.000522	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Capecitabine—colon cancer	6.73e-05	0.000522	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Methotrexate—colon cancer	6.71e-05	0.000521	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Capecitabine—colon cancer	6.71e-05	0.00052	CcSEcCtD
Mycophenolate mofetil—Vomiting—Vincristine—colon cancer	6.7e-05	0.00052	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Methotrexate—colon cancer	6.68e-05	0.000518	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Capecitabine—colon cancer	6.67e-05	0.000518	CcSEcCtD
Mycophenolate mofetil—Rash—Vincristine—colon cancer	6.65e-05	0.000516	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Capecitabine—colon cancer	6.64e-05	0.000515	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Vincristine—colon cancer	6.64e-05	0.000515	CcSEcCtD
Mycophenolate mofetil—Headache—Vincristine—colon cancer	6.6e-05	0.000512	CcSEcCtD
Mycophenolate mofetil—Anorexia—Capecitabine—colon cancer	6.55e-05	0.000508	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Methotrexate—colon cancer	6.53e-05	0.000507	CcSEcCtD
Mycophenolate mofetil—Vomiting—Irinotecan—colon cancer	6.53e-05	0.000506	CcSEcCtD
Mycophenolate mofetil—Dizziness—Fluorouracil—colon cancer	6.5e-05	0.000504	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Methotrexate—colon cancer	6.49e-05	0.000503	CcSEcCtD
Mycophenolate mofetil—Rash—Irinotecan—colon cancer	6.47e-05	0.000502	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Irinotecan—colon cancer	6.47e-05	0.000502	CcSEcCtD
Mycophenolate mofetil—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	6.46e-05	0.00142	CbGpPWpGaD
Mycophenolate mofetil—Chills—Methotrexate—colon cancer	6.46e-05	0.000501	CcSEcCtD
Mycophenolate mofetil—Headache—Irinotecan—colon cancer	6.43e-05	0.000499	CcSEcCtD
Mycophenolate mofetil—Hypotension—Capecitabine—colon cancer	6.42e-05	0.000498	CcSEcCtD
Mycophenolate mofetil—ABCG2—Metabolism—CA7—colon cancer	6.37e-05	0.0014	CbGpPWpGaD
Mycophenolate mofetil—Alopecia—Methotrexate—colon cancer	6.36e-05	0.000494	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Methotrexate—colon cancer	6.31e-05	0.000489	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Methotrexate—colon cancer	6.27e-05	0.000486	CcSEcCtD
Mycophenolate mofetil—Nausea—Vincristine—colon cancer	6.26e-05	0.000486	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Capecitabine—colon cancer	6.26e-05	0.000486	CcSEcCtD
Mycophenolate mofetil—Vomiting—Fluorouracil—colon cancer	6.25e-05	0.000485	CcSEcCtD
Mycophenolate mofetil—Insomnia—Capecitabine—colon cancer	6.21e-05	0.000482	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Metabolism—CHST5—colon cancer	6.21e-05	0.00137	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—ODC1—colon cancer	6.21e-05	0.00137	CbGpPWpGaD
Mycophenolate mofetil—Rash—Fluorouracil—colon cancer	6.2e-05	0.000481	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Fluorouracil—colon cancer	6.19e-05	0.00048	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Capecitabine—colon cancer	6.17e-05	0.000479	CcSEcCtD
Mycophenolate mofetil—Headache—Fluorouracil—colon cancer	6.16e-05	0.000478	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Methotrexate—colon cancer	6.14e-05	0.000476	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Capecitabine—colon cancer	6.13e-05	0.000475	CcSEcCtD
Mycophenolate mofetil—Nausea—Irinotecan—colon cancer	6.1e-05	0.000473	CcSEcCtD
Mycophenolate mofetil—Back pain—Methotrexate—colon cancer	6.06e-05	0.00047	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Capecitabine—colon cancer	6.05e-05	0.000469	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Capecitabine—colon cancer	5.97e-05	0.000463	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Capecitabine—colon cancer	5.93e-05	0.00046	CcSEcCtD
Mycophenolate mofetil—Pain—Capecitabine—colon cancer	5.88e-05	0.000456	CcSEcCtD
Mycophenolate mofetil—Constipation—Capecitabine—colon cancer	5.88e-05	0.000456	CcSEcCtD
Mycophenolate mofetil—ABCG2—HIF-1-alpha transcription factor network—EP300—colon cancer	5.84e-05	0.00129	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Fluorouracil—colon cancer	5.84e-05	0.000453	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Methotrexate—colon cancer	5.82e-05	0.000451	CcSEcCtD
Mycophenolate mofetil—Anaemia—Methotrexate—colon cancer	5.79e-05	0.000449	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Capecitabine—colon cancer	5.66e-05	0.000439	CcSEcCtD
Mycophenolate mofetil—Malaise—Methotrexate—colon cancer	5.65e-05	0.000438	CcSEcCtD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	5.65e-05	0.00124	CbGpPWpGaD
Mycophenolate mofetil—Vertigo—Methotrexate—colon cancer	5.63e-05	0.000437	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Capecitabine—colon cancer	5.62e-05	0.000436	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Methotrexate—colon cancer	5.61e-05	0.000435	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metabolism—CHST5—colon cancer	5.6e-05	0.00123	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—ODC1—colon cancer	5.6e-05	0.00123	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—HIF-1-alpha transcription factor network—VEGFA—colon cancer	5.53e-05	0.00122	CbGpPWpGaD
Mycophenolate mofetil—Cough—Methotrexate—colon cancer	5.47e-05	0.000424	CcSEcCtD
Mycophenolate mofetil—Urticaria—Capecitabine—colon cancer	5.46e-05	0.000423	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	5.44e-05	0.0012	CbGpPWpGaD
Mycophenolate mofetil—Abdominal pain—Capecitabine—colon cancer	5.43e-05	0.000421	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Capecitabine—colon cancer	5.43e-05	0.000421	CcSEcCtD
Mycophenolate mofetil—Convulsion—Methotrexate—colon cancer	5.43e-05	0.000421	CcSEcCtD
Mycophenolate mofetil—IMPDH2—Metabolism—ABCB1—colon cancer	5.36e-05	0.00118	CbGpPWpGaD
Mycophenolate mofetil—Chest pain—Methotrexate—colon cancer	5.34e-05	0.000414	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Methotrexate—colon cancer	5.34e-05	0.000414	CcSEcCtD
Mycophenolate mofetil—Myalgia—Methotrexate—colon cancer	5.34e-05	0.000414	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	5.3e-05	0.000411	CcSEcCtD
Mycophenolate mofetil—Discomfort—Methotrexate—colon cancer	5.27e-05	0.000409	CcSEcCtD
Mycophenolate mofetil—IMPDH2—Metabolism—TYMS—colon cancer	5.27e-05	0.00116	CbGpPWpGaD
Mycophenolate mofetil—Confusional state—Methotrexate—colon cancer	5.16e-05	0.0004	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Methotrexate—colon cancer	5.12e-05	0.000397	CcSEcCtD
Mycophenolate mofetil—Infection—Methotrexate—colon cancer	5.08e-05	0.000394	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Capecitabine—colon cancer	5.06e-05	0.000393	CcSEcCtD
Mycophenolate mofetil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	5.06e-05	0.00111	CbGpPWpGaD
Mycophenolate mofetil—Nervous system disorder—Methotrexate—colon cancer	5.02e-05	0.000389	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Methotrexate—colon cancer	5.01e-05	0.000388	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Methotrexate—colon cancer	4.97e-05	0.000385	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Methotrexate—colon cancer	4.95e-05	0.000384	CcSEcCtD
Mycophenolate mofetil—Asthenia—Capecitabine—colon cancer	4.93e-05	0.000382	CcSEcCtD
Mycophenolate mofetil—Anorexia—Methotrexate—colon cancer	4.88e-05	0.000378	CcSEcCtD
Mycophenolate mofetil—Pruritus—Capecitabine—colon cancer	4.86e-05	0.000377	CcSEcCtD
Mycophenolate mofetil—UGT1A7—Metabolism—ABCB1—colon cancer	4.78e-05	0.00105	CbGpPWpGaD
Mycophenolate mofetil—Hypotension—Methotrexate—colon cancer	4.78e-05	0.000371	CcSEcCtD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	4.75e-05	0.00105	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	4.72e-05	0.00104	CbGpPWpGaD
Mycophenolate mofetil—Diarrhoea—Capecitabine—colon cancer	4.7e-05	0.000365	CcSEcCtD
Mycophenolate mofetil—UGT1A7—Metabolism—TYMS—colon cancer	4.69e-05	0.00103	CbGpPWpGaD
Mycophenolate mofetil—Musculoskeletal discomfort—Methotrexate—colon cancer	4.66e-05	0.000361	CcSEcCtD
Mycophenolate mofetil—Insomnia—Methotrexate—colon cancer	4.63e-05	0.000359	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Methotrexate—colon cancer	4.59e-05	0.000356	CcSEcCtD
Mycophenolate mofetil—UGT1A9—PPARA activates gene expression—EP300—colon cancer	4.58e-05	0.00101	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CA7—colon cancer	4.57e-05	0.001	CbGpPWpGaD
Mycophenolate mofetil—Dyspnoea—Methotrexate—colon cancer	4.56e-05	0.000354	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Metabolism—CHST5—colon cancer	4.55e-05	0.001	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—ODC1—colon cancer	4.55e-05	0.001	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CHST5—colon cancer	4.55e-05	0.001	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—ODC1—colon cancer	4.55e-05	0.001	CbGpPWpGaD
Mycophenolate mofetil—Somnolence—Methotrexate—colon cancer	4.55e-05	0.000353	CcSEcCtD
Mycophenolate mofetil—Dizziness—Capecitabine—colon cancer	4.54e-05	0.000352	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Methotrexate—colon cancer	4.5e-05	0.000349	CcSEcCtD
Mycophenolate mofetil—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	4.48e-05	0.000986	CbGpPWpGaD
Mycophenolate mofetil—Decreased appetite—Methotrexate—colon cancer	4.45e-05	0.000345	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Methotrexate—colon cancer	4.42e-05	0.000343	CcSEcCtD
Mycophenolate mofetil—Pain—Methotrexate—colon cancer	4.37e-05	0.000339	CcSEcCtD
Mycophenolate mofetil—IMPDH1—Metabolism—ABCB1—colon cancer	4.37e-05	0.000962	CbGpPWpGaD
Mycophenolate mofetil—Vomiting—Capecitabine—colon cancer	4.37e-05	0.000339	CcSEcCtD
Mycophenolate mofetil—Rash—Capecitabine—colon cancer	4.33e-05	0.000336	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Capecitabine—colon cancer	4.33e-05	0.000336	CcSEcCtD
Mycophenolate mofetil—Headache—Capecitabine—colon cancer	4.3e-05	0.000334	CcSEcCtD
Mycophenolate mofetil—IMPDH1—Metabolism—TYMS—colon cancer	4.29e-05	0.000945	CbGpPWpGaD
Mycophenolate mofetil—Feeling abnormal—Methotrexate—colon cancer	4.22e-05	0.000327	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Methotrexate—colon cancer	4.18e-05	0.000324	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Metabolism—ODC1—colon cancer	4.17e-05	0.000918	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CHST5—colon cancer	4.17e-05	0.000918	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Capecitabine—colon cancer	4.08e-05	0.000317	CcSEcCtD
Mycophenolate mofetil—Urticaria—Methotrexate—colon cancer	4.06e-05	0.000315	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Methotrexate—colon cancer	4.04e-05	0.000314	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Methotrexate—colon cancer	4.04e-05	0.000314	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Metabolism—CA7—colon cancer	3.96e-05	0.00087	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CA7—colon cancer	3.93e-05	0.000865	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—NRF2 pathway—TGFB1—colon cancer	3.9e-05	0.000859	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CHST5—colon cancer	3.86e-05	0.00085	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ODC1—colon cancer	3.86e-05	0.00085	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	3.8e-05	0.000836	CbGpPWpGaD
Mycophenolate mofetil—Hypersensitivity—Methotrexate—colon cancer	3.77e-05	0.000292	CcSEcCtD
Mycophenolate mofetil—IMPDH2—Metabolism—PPARG—colon cancer	3.73e-05	0.000821	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—ABCB1—colon cancer	3.72e-05	0.000818	CbGpPWpGaD
Mycophenolate mofetil—Asthenia—Methotrexate—colon cancer	3.67e-05	0.000285	CcSEcCtD
Mycophenolate mofetil—UGT1A8—Metabolism—TYMS—colon cancer	3.65e-05	0.000803	CbGpPWpGaD
Mycophenolate mofetil—Pruritus—Methotrexate—colon cancer	3.62e-05	0.000281	CcSEcCtD
Mycophenolate mofetil—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	3.53e-05	0.000777	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Transmembrane transport of small molecules—ABCB1—colon cancer	3.5e-05	0.000771	CbGpPWpGaD
Mycophenolate mofetil—Diarrhoea—Methotrexate—colon cancer	3.5e-05	0.000271	CcSEcCtD
Mycophenolate mofetil—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	3.49e-05	0.000769	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CA7—colon cancer	3.45e-05	0.000758	CbGpPWpGaD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	3.44e-05	0.000758	CbGpPWpGaD
Mycophenolate mofetil—Dizziness—Methotrexate—colon cancer	3.38e-05	0.000262	CcSEcCtD
Mycophenolate mofetil—UGT1A7—Metabolism—PPARG—colon cancer	3.33e-05	0.000732	CbGpPWpGaD
Mycophenolate mofetil—Vomiting—Methotrexate—colon cancer	3.25e-05	0.000252	CcSEcCtD
Mycophenolate mofetil—Rash—Methotrexate—colon cancer	3.23e-05	0.00025	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Methotrexate—colon cancer	3.22e-05	0.00025	CcSEcCtD
Mycophenolate mofetil—Headache—Methotrexate—colon cancer	3.2e-05	0.000249	CcSEcCtD
Mycophenolate mofetil—UGT1A1—NRF2 pathway—TGFB1—colon cancer	3.17e-05	0.000698	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—NRF2 pathway—TGFB1—colon cancer	3.17e-05	0.000698	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	3.16e-05	0.000695	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—NRF2 pathway—TGFB1—colon cancer	3.1e-05	0.000681	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	3.09e-05	0.000679	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—CASP3—colon cancer	3.05e-05	0.000672	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—PPARG—colon cancer	3.04e-05	0.000669	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Methotrexate—colon cancer	3.04e-05	0.000236	CcSEcCtD
Mycophenolate mofetil—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	3.01e-05	0.000663	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	2.99e-05	0.000658	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—PTGS2—colon cancer	2.94e-05	0.000646	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet degranulation—VEGFA—colon cancer	2.93e-05	0.000644	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	2.91e-05	0.000641	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	2.81e-05	0.000618	CbGpPWpGaD
Mycophenolate mofetil—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	2.79e-05	0.000614	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CHST5—colon cancer	2.77e-05	0.000609	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ODC1—colon cancer	2.77e-05	0.000609	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—ABCB1—colon cancer	2.71e-05	0.000597	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet degranulation—TGFB1—colon cancer	2.69e-05	0.000591	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—TYMS—colon cancer	2.66e-05	0.000586	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—PTGS2—colon cancer	2.62e-05	0.000576	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—VEGFA—colon cancer	2.59e-05	0.00057	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—PPARG—colon cancer	2.59e-05	0.000569	CbGpPWpGaD
Mycophenolate mofetil—ALB—Folate Metabolism—TP53—colon cancer	2.58e-05	0.000568	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.56e-05	0.000564	CbGpPWpGaD
Mycophenolate mofetil—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	2.56e-05	0.000563	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.51e-05	0.000551	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—EP300—colon cancer	2.44e-05	0.000537	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CHST5—colon cancer	2.4e-05	0.000527	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ODC1—colon cancer	2.4e-05	0.000527	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—PTGS2—colon cancer	2.39e-05	0.000527	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CHST5—colon cancer	2.38e-05	0.000524	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ODC1—colon cancer	2.38e-05	0.000524	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—TGFB1—colon cancer	2.38e-05	0.000523	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—ABCB1—colon cancer	2.35e-05	0.000518	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.18e-05	0.000479	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—EP300—colon cancer	2.18e-05	0.000479	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.14e-05	0.000471	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CA7—colon cancer	2.12e-05	0.000467	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ODC1—colon cancer	2.09e-05	0.000459	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CHST5—colon cancer	2.09e-05	0.000459	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—PTGS2—colon cancer	2.03e-05	0.000448	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.02e-05	0.000444	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—EP300—colon cancer	1.99e-05	0.000438	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.91e-05	0.00042	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PPARG—colon cancer	1.89e-05	0.000415	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.88e-05	0.000413	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—PIK3CA—colon cancer	1.81e-05	0.000397	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.72e-05	0.000379	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—EP300—colon cancer	1.69e-05	0.000372	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.68e-05	0.000369	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—ABCB1—colon cancer	1.64e-05	0.000361	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.62e-05	0.000357	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—TYMS—colon cancer	1.61e-05	0.000354	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—PIK3CA—colon cancer	1.61e-05	0.000354	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.51e-05	0.000332	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PTGS2—colon cancer	1.48e-05	0.000327	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—ABCB1—colon cancer	1.48e-05	0.000326	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.48e-05	0.000325	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—AKT1—colon cancer	1.48e-05	0.000325	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—PIK3CA—colon cancer	1.47e-05	0.000324	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.47e-05	0.000323	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—TYMS—colon cancer	1.45e-05	0.00032	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.45e-05	0.00032	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.42e-05	0.000312	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.35e-05	0.000298	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.35e-05	0.000297	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	1.34e-05	0.000296	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	1.33e-05	0.000293	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—AKT1—colon cancer	1.31e-05	0.000289	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.31e-05	0.000289	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	1.3e-05	0.000286	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CHST5—colon cancer	1.29e-05	0.000283	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ODC1—colon cancer	1.29e-05	0.000283	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.28e-05	0.000281	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—PIK3CA—colon cancer	1.25e-05	0.000275	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.24e-05	0.000273	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—EP300—colon cancer	1.23e-05	0.000272	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.23e-05	0.00027	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—AKT1—colon cancer	1.2e-05	0.000265	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—ABCB1—colon cancer	1.2e-05	0.000265	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—ABCB1—colon cancer	1.2e-05	0.000265	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	1.19e-05	0.000262	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—TYMS—colon cancer	1.18e-05	0.00026	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—TYMS—colon cancer	1.18e-05	0.00026	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.18e-05	0.000259	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.17e-05	0.000258	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.15e-05	0.000253	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PPARG—colon cancer	1.14e-05	0.000251	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.13e-05	0.000248	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ABCB1—colon cancer	1.1e-05	0.000242	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.09e-05	0.000239	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—TYMS—colon cancer	1.08e-05	0.000238	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PPARG—colon cancer	1.03e-05	0.000227	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—AKT1—colon cancer	1.02e-05	0.000225	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ABCB1—colon cancer	1.02e-05	0.000225	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	1.01e-05	0.000223	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—TYMS—colon cancer	1e-05	0.000221	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	9.99e-06	0.00022	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.89e-06	0.000218	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.84e-06	0.000216	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	9.66e-06	0.000213	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PIK3CA—colon cancer	9.13e-06	0.000201	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	9.09e-06	0.0002	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PTGS2—colon cancer	8.98e-06	0.000198	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PPARG—colon cancer	8.37e-06	0.000184	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PPARG—colon cancer	8.37e-06	0.000184	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.33e-06	0.000183	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	8.29e-06	0.000182	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	8.16e-06	0.00018	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PTGS2—colon cancer	8.1e-06	0.000178	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.78e-06	0.000171	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.74e-06	0.00017	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PPARG—colon cancer	7.67e-06	0.000169	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—EP300—colon cancer	7.47e-06	0.000164	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—AKT1—colon cancer	7.46e-06	0.000164	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ABCB1—colon cancer	7.31e-06	0.000161	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—TYMS—colon cancer	7.18e-06	0.000158	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PPARG—colon cancer	7.1e-06	0.000156	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—EP300—colon cancer	7.07e-06	0.000156	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—SRC—colon cancer	6.87e-06	0.000151	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—EP300—colon cancer	6.74e-06	0.000148	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—VEGFA—colon cancer	6.69e-06	0.000147	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—NRAS—colon cancer	6.61e-06	0.000146	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PTGS2—colon cancer	6.58e-06	0.000145	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PTGS2—colon cancer	6.58e-06	0.000145	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.47e-06	0.000142	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.44e-06	0.000142	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ABCB1—colon cancer	6.33e-06	0.000139	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ABCB1—colon cancer	6.3e-06	0.000139	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—TYMS—colon cancer	6.22e-06	0.000137	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—TYMS—colon cancer	6.18e-06	0.000136	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TGFB1—colon cancer	6.14e-06	0.000135	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PTGS2—colon cancer	6.03e-06	0.000133	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—KRAS—colon cancer	5.69e-06	0.000125	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PTGS2—colon cancer	5.58e-06	0.000123	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PIK3CA—colon cancer	5.52e-06	0.000122	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—EP300—colon cancer	5.47e-06	0.00012	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—EP300—colon cancer	5.47e-06	0.00012	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—TYMS—colon cancer	5.42e-06	0.000119	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3CA—colon cancer	5.23e-06	0.000115	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PPARG—colon cancer	5.09e-06	0.000112	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TP53—colon cancer	5.06e-06	0.000111	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—EP300—colon cancer	5.02e-06	0.00011	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3CA—colon cancer	4.98e-06	0.00011	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—HRAS—colon cancer	4.84e-06	0.000106	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.79e-06	0.000105	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.76e-06	0.000105	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—EP300—colon cancer	4.64e-06	0.000102	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—AKT1—colon cancer	4.51e-06	9.93e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PPARG—colon cancer	4.41e-06	9.69e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PPARG—colon cancer	4.38e-06	9.64e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—AKT1—colon cancer	4.27e-06	9.4e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—AKT1—colon cancer	4.07e-06	8.96e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CA—colon cancer	4.05e-06	8.91e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CA—colon cancer	4.05e-06	8.91e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PTGS2—colon cancer	4e-06	8.8e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PPARG—colon cancer	3.84e-06	8.45e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CA—colon cancer	3.71e-06	8.17e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PTGS2—colon cancer	3.47e-06	7.63e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PTGS2—colon cancer	3.45e-06	7.58e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CA—colon cancer	3.44e-06	7.56e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ABCB1—colon cancer	3.4e-06	7.48e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—TYMS—colon cancer	3.34e-06	7.35e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—EP300—colon cancer	3.33e-06	7.32e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—AKT1—colon cancer	3.31e-06	7.28e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—AKT1—colon cancer	3.31e-06	7.28e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—AKT1—colon cancer	3.03e-06	6.67e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PTGS2—colon cancer	3.02e-06	6.64e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—EP300—colon cancer	2.88e-06	6.34e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—EP300—colon cancer	2.87e-06	6.31e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—AKT1—colon cancer	2.81e-06	6.18e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—EP300—colon cancer	2.51e-06	5.53e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CA—colon cancer	2.46e-06	5.42e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PPARG—colon cancer	2.36e-06	5.2e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CA—colon cancer	2.13e-06	4.69e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CA—colon cancer	2.12e-06	4.67e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—AKT1—colon cancer	2.01e-06	4.43e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PTGS2—colon cancer	1.86e-06	4.09e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CA—colon cancer	1.86e-06	4.09e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—AKT1—colon cancer	1.74e-06	3.83e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—AKT1—colon cancer	1.73e-06	3.81e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—EP300—colon cancer	1.55e-06	3.4e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—AKT1—colon cancer	1.52e-06	3.34e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CA—colon cancer	1.14e-06	2.52e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—AKT1—colon cancer	9.35e-07	2.06e-05	CbGpPWpGaD
